Trademark: 79347683
Word
CELAID THERAPEUTICS
Status Date
Tuesday, March 12, 2024
Registration Number
7324426
Registration Date
Tuesday, March 12, 2024
Filing Date
Wednesday, May 18, 2022
Published for Opposition
Tuesday, December 26, 2023
40 Treatment and processing of human cells for others; treatment and processing of cells for medical use; cryogenic preservation; custom manufacture of pharmaceutical preparations for others; treatment and processing of blood and blood products
5 Pharmaceutical preparations for the prevention and treatment of cancers; pharmaceutical preparations for the prevention and treatment of hematological malignancies; pharmaceutical preparations for the prevention and treatment of non-hematological malignancies; pharmaceutical preparations for the prevention and treatment of genetic disorders; pharmaceutical preparations for use as gene therapy agent; pharmaceutical preparations for use as regenerative medicine agent; cells for medical use; blood products for the prevention and treatment of cancers; blood products for the prevention and treatment of hematological malignancies; blood products for the prevention and treatment of non-hematological malignancies; blood products for the prevention and treatment of genetic disorders; blood products for use as gene therapy agent; blood products for use as regenerative medicine agent; blood for medical purposes; hemotropic agents for stimulation of cell function, gene therapy, cell therapy, and for use as blood substitutes; cellular function activating agents for medical purposes; reagents for medical use; cell preparations for the treatment of diseases and disorders; clinical diagnostic reagents; stem cells for medical purposes
1 Chemical reagents for non-medical purposes, chemicals for use in the manufacture of pharmaceuticals; reagents for scientific and research use
44 Blood testing and analysis; provision of information on blood tests; providing medical information and consultation; blood bank services; rental of blood filtration units; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow
42 Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs
The mark consists of the stylized word "CELAID" with the letters "CELA" and "D" in black and the letter "I" in pink. The stylized word "THERAPEUTICS" appears below in black. To the left of the wording, the design of two irregular circles appears, with the lower circle in pink and the upper circle in blue. The overlapping area of the circles appears in purple.
The color(s) black, pink, blue, and purple is/are claimed as a feature of the mark.
"THERAPEUTICS"
Aug 18, 2022
Sn Assigned For Sect 66a Appl From Ib
Aug 19, 2022
New Application Office Supplied Data Entered
Aug 23, 2022
Application Filing Receipt Mailed
Mar 8, 2023
Assigned To Examiner
Mar 10, 2023
Non-Final Action Written
Mar 11, 2023
Non-Final Action (Ib Refusal) Prepared For Review
May 1, 2023
Refusal Processed By Mpu
May 1, 2023
Non-Final Action Mailed - Refusal Sent To Ib
May 24, 2023
Refusal Processed By Ib
Nov 1, 2023
Teas Response To Office Action Received
Nov 1, 2023
Correspondence Received In Law Office
Nov 1, 2023
Teas/Email Correspondence Entered
Nov 17, 2023
Approved For Pub - Principal Register
Dec 6, 2023
Notification Of Possible Opposition Sent To Ib
Dec 6, 2023
Notification Of Notice Of Publication E-Mailed
Dec 6, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 26, 2023
Notification Processed By Ib
Dec 26, 2023
Published For Opposition
Jan 24, 2024
Notification Of Possible Opposition Sent To Ib
Jan 24, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Dec 26, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 13, 2024
Notification Of Possible Opposition - Processed By Ib
Mar 12, 2024
Registered-Principal Register
Mar 12, 2024
Notice Of Registration Confirmation Emailed
Jun 13, 2024
Final Disposition Notice Created, To Be Sent To Ib
Jul 19, 2024
Final Disposition Notice Sent To Ib
Aug 11, 2024
Final Decision Transaction Processed By Ib
Jul 19, 2024
Final Disposition Processed
Trademark Alertz updated from USPTO on 2030-01-24
